View Generic ICR - OIRA Conclusion



0910-0500 200710-0910-002
Historical Active 200603-0910-009
HHS/FDA
Generic FDA Rapid Response Surveys
Extension without change of a currently approved collection   No
Regular
Approved with change 01/04/2008
10/11/2007
This generic clearance for FDA focus groups is approved for 3 years consistent with the FDA revised supporting statement and under the following conditions: 1) FDA shall submit memos for individual surveys (e.g., statement of need for rapid response, intended use of information, description of respondents, information collection procedures, expected response rate, justification for incentive, estimated burden, survey instrument) 2) OMB will respond with clearance or questions within 10 working days 3) OMB and FDA will jointly evaluate the generic clearance upon resubmission in 3 years. Upon resubmission, FDA will provide a summary of each collection approved under the generic clearance (e.g., actual response rate, representativeness of data, use of information). OMB notes that this generic information collection request has been expanded to include CFSAN-related uses. OMB will work with FDA throughout the clearance period to ensure a mutual understanding of the appropriate uses of this clearance in the new context. OMB further notes that the milk rapid response survey is not approved at this time. However, FDA may resubmit it as an individual item under this generic approval without delay.
  Inventory as of this Action Requested Previously Approved
01/31/2011 36 Months From Approved 01/31/2008
6,000 0 6,000
3,000 0 3,000
0 0 0